Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.95
+5.65 (2.36%)
AAPL  264.32
+4.84 (1.87%)
AMD  248.20
+11.47 (4.85%)
BAC  53.95
+0.75 (1.41%)
GOOG  342.79
+4.26 (1.26%)
META  706.35
-10.15 (-1.42%)
MSFT  424.99
-5.30 (-1.23%)
NVDA  189.39
-1.74 (-0.91%)
ORCL  168.07
+3.49 (2.12%)
TSLA  423.25
-7.16 (-1.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.